SCHEMBL29973191

SCHEMBL29973191

C=C(Cc1nc(Cc2ccc3ccccc3c2)no1)C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ ZAP70 P43403 4/20 0.38
▸ SRC P12931 3/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ CTSB P07858 1/20 0.36
▸ CTSS P25774 1/20 0.36
▸ CTSK P43235 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ PSMB5 P28074 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23578293 1.00 TSHR (0.38) TSHRMAPK1TDP1ZAP70SRC
SCHEMBL23578299 0.85 TSHR (0.51) TSHRMAPK1TDP1ZAP70SRC
SCHEMBL29973380 0.85 TSHR (0.51) TSHRMAPK1TDP1ZAP70SRC
SCHEMBL23578571 0.84 MAPT (0.35) TSHRMAPK1TDP1L3MBTL1MEN1
SCHEMBL23578197 0.84 MAPT (0.47) TSHRMAPK1TDP1L3MBTL1MEN1
SCHEMBL23578414 0.84 TP53 (0.38) TSHRMAPK1TDP1MEN1KMT2A
SCHEMBL29844025 0.83 TSHR (0.46) TSHRMAPK1TDP1ZAP70SRC
SCHEMBL23588255 0.83 TSHR (0.46) TSHRMAPK1TDP1ZAP70SRC
SCHEMBL25801971 0.83 MAPT (0.35) TSHRL3MBTL1MEN1KMT2AMAPT
SCHEMBL23578189 0.82 MAPT (0.38) MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081511-B3 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES SITRYX THERAPEUTICS LTD (GB) 2026-03-04 — — EP disclosed
EP-4081511-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES Sitryx Therapeutics Limited (GB) 2022-11-02 — — EP disclosed
Send feedback